Concepedia

Priyadharsini Nagarajan

PN

73

Publications

2.5K

Citations

29

H-Index

2007

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University at Buffalo, State University of New York

Baylor College of Medicine

Priyadharsini Nagarajan is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and dermatology.

ORCID

Top concepts

Publications per year

2007–2025

73

Publications

73

Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients

Michael T. Tetzlaff, Kelly C. Nelson, Adi Diab et al. · Journal for ImmunoTherapy of Cancer · 2018 · 150 citations · Full text

Pilot Phase II Trial of Neoadjuvant Immunotherapy in Locoregionally Advanced, Resectable Cutaneous Squamous Cell Carcinoma of the Head and Neck

Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan et al. · Clinical Cancer Research · 2021 · 132 citations · Full text

Autoimmune dermatologic toxicities from immune checkpoint blockade with anti‐<scp>PD</scp>‐1 antibody therapy: a report on bullous skin eruptions

George Jour, Isabella C. Glitza, Rachel M. Ellis et al. · Journal of Cutaneous Pathology · 2016 · 130 citations

, , +20

Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features

Michael T. Tetzlaff, Priyadharsini Nagarajan, Susan Y. Chon et al. · American Journal of Dermatopathology · 2017 · 110 citations

Density, Distribution, and Composition of Immune Infiltrates Correlate with Survival in Merkel Cell Carcinoma

Laurence Feldmeyer, Courtney W. Hudgens, Genevieve Ray-Lyons et al. · Clinical Cancer Research · 2016 · 106 citations · Full text

Rows per page

1–5 of 73